Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Light Induced Radical Cyclization. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121248372A enables catalyst-free visible light synthesis. Offers sustainable cost reduction and scalable supply chain solutions for high-purity pharmaceutical intermediates.
Patent CN118255706B reveals a photocatalyst-free oxindole synthesis. High yield, mild conditions, cost-effective for pharmaceutical intermediate manufacturing.
Novel visible-light method for 2-trifluoromethyl-3-aminoindole. Cost-effective, metal-free process ensures reliable supply chain for pharma intermediates.
Novel light-induced patent CN116606239B enables metal-free synthesis. Delivers high-purity intermediates with reduced costs and scalable supply chain solutions.